Search Results - Randy Strong

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Nuclei Isolation from Bone Cells for Nuclear Run-on Assays by Narayanasamy Elango, Jeevalatha Vivekananda, Randy Strong, Michael S. Katz

    Published in BioTechniques (1997-09-01)
    Get full text
    Article


  2. 2

    NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model by Nancy L. Nadon, Randy Strong, Richard A. Miller, David E. Harrison

    Published in EBioMedicine (2017-07-01)
    Get full text
    Article


  3. 3

    Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease. by Margaret Chia-Ying Wey, Elizabeth Fernandez, Paul Anthony Martinez, Patricia Sullivan, David S Goldstein, Randy Strong

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  4. 4

    Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease. by Xiuhua Li, Laney Redus, Cang Chen, Paul A Martinez, Randy Strong, Senlin Li, Jason C O'Connor

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  5. 5

    Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. by Patricia Spilman, Natalia Podlutskaya, Matthew J Hart, Jayanta Debnath, Olivia Gorostiza, Dale Bredesen, Arlan Richardson, Randy Strong, Veronica Galvan

    Published in PLoS ONE (2010-04-01)
    Get full text
    Article


  6. 6

    Development of primary osteoarthritis during aging in genetically diverse UM-HET3 mice by Sher Bahadur Poudel, Ryan R. Ruff, Gozde Yildirim, Richard A. Miller, David E. Harrison, Randy Strong, Thorsten Kirsch, Shoshana Yakar

    Published in Arthritis Research & Therapy (2024-06-01)
    Get full text
    Article


  7. 7

    Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease by Paul Anthony Martinez, Vanessa Elia Martinez, Sheela Rani, Meredith Murrell, Martin Javors, Jonathan Gelfond, Jonathan Alan Doorn, Elizabeth Fernandez, Randy Strong

    Published in Brain and Behavior (2023-09-01)
    Get full text
    Article


  8. 8

    DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease by Anna Masato, Nicoletta Plotegher, Francesca Terrin, Michele Sandre, Gaia Faustini, Andrea Thor, Stephen Adams, Giulia Berti, Susanna Cogo, Federica De Lazzari, Camilla Maria Fontana, Paul Anthony Martinez, Randy Strong, Rina Bandopadhyay, Marco Bisaglia, Arianna Bellucci, Elisa Greggio, Luisa Dalla Valle, Daniela Boassa, Luigi Bubacco

    Published in npj Parkinson's Disease (2023-03-01)
    Get full text
    Article


  9. 9

    Canagliflozin extends life span in genetically heterogeneous male but not female mice by Richard A. Miller, David E. Harrison, David B. Allison, Molly Bogue, Lucas Debarba, Vivian Diaz, Elizabeth Fernandez, Andrzej Galecki, W. Timothy Garvey, Hashan Jayarathne, Navasuja Kumar, Martin A. Javors, Warren C. Ladiges, Francesca Macchiarini, James Nelson, Peter Reifsnyder, Nadia A. Rosenthal, Marianna Sadagurski, Adam B. Salmon, Daniel L. Smith Jr., Jessica M. Snyder, David B. Lombard, Randy Strong

    Published in JCI Insight (2020-11-01)
    Get full text
    Article


Search Tools: